Opportunity Overview
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.
This is one of 1,276 active United States Health Services opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | National Institutes of Health |
|---|---|
| Country | United States |
| Category | Health Services |
| NAICS | 93.393 |
| Published | November 18, 2024 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | January 07, 2027 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 11, 2026 |
Source: U.S. Government (Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
See every United States Health Services opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Health Services intelligence report in your inbox
A personalized report on United States Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.